Signal transduction and targeted therapy
Limited SUMOylation inhibitor administration enhances eradication of Burkitt's lymphoma with CD19 CAR-T therapy.
Hiroshi Kotani, Shigeki Sato, Seiji Yano, Marco L Davila, Hiroaki Taniguchi
Published: 202510.1038/s41392-025-02422-5
No abstract available for this study.